| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 7e-06 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |